Inventor · disambiguated record
Nestor F. Gonzalez-Cadavid
Also filed as: GONZALEZ-CADAVID NESTOR F
4 granted patents·8 pending applications·84 citations·filing 1994–2021
77Inventor score
Files withLOS ANGELES BIOMED RES INST3GONZALEZ-CADAVID NESTOR F2HARBOR UCLA RES & EDUCATION1LOS ANGELES BIOMEDICAL RES INST AT HARBOR-UCLA MEDICAL CENTER1LOS ANGELES BIOMEDICAL RES INST HARBOR UCLA MEDICAL CT1
Top patents by PatentIndex Score
12 records- 0177US5594032AAmelioration of human erectile dysfunction by treatment with iNOS, inducers of iNOS or iNOS cDNAFiled 1994·Granted Jan 14, 1997·61 cites·11 claims
- 0265US8426374B1Method for modifying myostatin expressionMAGEE THOMAS R·Filed 2007·Granted Apr 23, 2013·3 cites·16 claims
- 0365US8133903B2Methods of use of inhibitors of phosphodiesterases and modulators of nitric oxide, reactive oxygen species, and metalloproteinases in the treatment of peyronie's disease, arteriosclerosis and other fibrotic diseasesGONZALEZ-CADAVID NESTOR F·Filed 2004·Granted Mar 13, 2012·3 cites·5 claims
- 0465US2020000811A1Methods of use of inhibitors of phosphodiesterases and modulators of nitric oxide, reactive oxygen species, and metalloproteinases in the treatment of peyronie's disease, arteriosclerosis and other fibrotic diseasesLOS ANGELES BIOMEDICAL RES INST HARBOR UCLA MEDICAL CT·Filed 2019·Application pending·0 cites
- 0562US2014350021A1Methods of Use of Inhibitors of Phosphodiesterases and Modulators of Nitric Oxide, Reactive Oxygen Species, and Metalloproteinases in the Treatment of Peyronie's Disease, Arteriosclerosis and Other Fibrotic DiseasesLOS ANGELES BIOMED RES INST·Filed 2014·Application pending·0 cites
- 0661US2018318307A1Methods of use of inhibitors of phosphodiesterases and modulators of nitric oxide, reactive oxygen species, and metalloproteinases in the treatment of peyronie's disease, arteriosclerosis and other fibrotic diseasesLOS ANGELES BIOMEDICAL RES INSTITUTE AT HARBO·Filed 2017·Application pending·0 cites
- 0761US2014200219A1Methods of Use of Inhibitors of Phosphodiesterases and Modulators of Nitric Oxide, Reactive Oxygen Species, and Metalloproteinases in the Treatment of Peyronie's Disease, Arteriosclerosis and Other Fibrotic DiseasesLOS ANGELES BIOMED RES INST·Filed 2014·Application pending·0 cites
- 0858US2017239257A1Methods of Use of Inhibitors of Phosphodiesterases and Modulators of Nitric Oxide, Reactive Oxygen Species, and Metalloproteinases in the Treatment of Peyronie's Disease, Arteriosclerosis and Other Fibrotic DiseasesLOS ANGELES BIOMEDICAL RES INST AT HARBOR- UCLA MEDICAL CENTER·Filed 2016·Application pending·0 cites
- 0953US6133281ANMDA receptor blockers in the therapy of urogenital diseaseHARBOR UCLA RES & EDUCATION·Filed 1997·Granted Oct 17, 2000·17 cites·3 claims
- 1052US2021189490A1MicroRNA Transcriptional Signature (miR-TS) Evaluation of Stem CellsLUNDQUIST INST FOR BIOMEDICAL INNOVATION AT HARBOR UCLA MEDICAL CENTER·Filed 2021·Application pending·0 cites
- 1152US2012141454A1Methods of Use of Inhibitors of Phosphodiesterases and Modulators of Nitric Oxide, Reactive Oxygen Species, and Metalloproteinases in the Treatment of Peyronie's Disease, Arteriosclerosis and Other Fibrotic DiseasesGONZALEZ-CADAVID NESTOR F·Filed 2012·Application pending·0 cites
- 1245US2015328249A1Modulation of myofiber repair by anti-myostatin strategies and/or ppar gamma ligands, alone or in combination with stem cells, for the therapy of critical limb ischemia and other ischemic processes affecting the skeletal muscleLOS ANGELES BIOMED RES INST·Filed 2013·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Nestor F. Gonzalez-Cadavid files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →